279 related articles for article (PubMed ID: 31998788)
41. Bioinformatic identification of renal cell carcinoma microenvironment-associated biomarkers with therapeutic and prognostic value.
Zeng Q; Zhang W; Li X; Lai J; Li Z
Life Sci; 2020 Feb; 243():117273. PubMed ID: 31926244
[TBL] [Abstract][Full Text] [Related]
42. Gene expression profiling separates chromophobe renal cell carcinoma from oncocytoma and identifies vesicular transport and cell junction proteins as differentially expressed genes.
Rohan S; Tu JJ; Kao J; Mukherjee P; Campagne F; Zhou XK; Hyjek E; Alonso MA; Chen YT
Clin Cancer Res; 2006 Dec; 12(23):6937-45. PubMed ID: 17145811
[TBL] [Abstract][Full Text] [Related]
43. Identification of EGFR as a Novel Key Gene in Clear Cell Renal Cell Carcinoma (ccRCC) through Bioinformatics Analysis and Meta-Analysis.
Wang S; Yu ZH; Chai KQ
Biomed Res Int; 2019; 2019():6480865. PubMed ID: 30895194
[TBL] [Abstract][Full Text] [Related]
44. Identification of TYROBP and FCER1G as Key Genes with Prognostic Value in Clear Cell Renal Cell Carcinoma by Bioinformatics Analysis.
Wang L; Lin Y; Yuan Y; Liu F; Sun K
Biochem Genet; 2021 Oct; 59(5):1278-1294. PubMed ID: 33786672
[TBL] [Abstract][Full Text] [Related]
45. Analysis of genes associated with prognosis of lung adenocarcinoma based on GEO and TCGA databases.
Yu Y; Tian X
Medicine (Baltimore); 2020 May; 99(19):e20183. PubMed ID: 32384511
[TBL] [Abstract][Full Text] [Related]
46. Bioinformatics analysis and verification of gene targets for renal clear cell carcinoma.
Li F; Jin Y; Pei X; Guo P; Dong K; Wang H; Chen Y; Guo P; Meng LB; Wang Z
Comput Biol Chem; 2021 Jun; 92():107453. PubMed ID: 33636636
[TBL] [Abstract][Full Text] [Related]
47. Does chromophobe renal cell carcinoma have better survival than clear cell renal cell carcinoma? A clinical-based cohort study and meta-analysis.
Jiang HM; Wei JH; Zhang ZL; Fang Y; Zhou BF; Chen ZH; Lu J; Liao B; Zhou FJ; Luo JH; Chen W
Int Urol Nephrol; 2016 Feb; 48(2):191-9. PubMed ID: 26589610
[TBL] [Abstract][Full Text] [Related]
48. Alpha-2-Heremans-Schmid-glycoprotein (AHSG) a potential biomarker associated with prognosis of chromophobe renal cell carcinoma: The PROPOLIS study.
Li X; Ma C
Health Sci Rep; 2022 Nov; 5(6):e878. PubMed ID: 36262809
[TBL] [Abstract][Full Text] [Related]
49. Morphological, immunohistochemical, and chromosomal analysis of multicystic chromophobe renal cell carcinoma, an architecturally unusual challenging variant.
Foix MP; Dunatov A; Martinek P; Mundó EC; Suster S; Sperga M; Lopez JI; Ulamec M; Bulimbasic S; Montiel DP; Alaghehbandan R; Peckova K; Pivovarcikova K; Ondrej D; Rotterova P; Skenderi F; Prochazkova K; Dusek M; Hora M; Michal M; Hes O
Virchows Arch; 2016 Dec; 469(6):669-678. PubMed ID: 27631338
[TBL] [Abstract][Full Text] [Related]
50. Insertion (8;11) in a renal oncocytoma with multifocal transformation to chromophobe renal cell carcinoma.
Salido M; Lloreta J; Melero C; García M; Placer J; Espinet B; Villa O; Bielsa O; Gelabert-Mas A; Serrano S; Solé F
Cancer Genet Cytogenet; 2005 Dec; 163(2):160-3. PubMed ID: 16337860
[TBL] [Abstract][Full Text] [Related]
51. LMP2, a novel immunohistochemical marker to distinguish renal oncocytoma from the eosinophilic variant of chromophobe renal cell carcinoma.
Zheng G; Chaux A; Sharma R; Netto G; Caturegli P
Exp Mol Pathol; 2013 Feb; 94(1):29-32. PubMed ID: 22705098
[TBL] [Abstract][Full Text] [Related]
52. FMR1 is identified as an immune-related novel prognostic biomarker for renal clear cell carcinoma: A bioinformatics analysis of TAZ/YAP.
Wu S; He H; Huang J; Jiang S; Deng X; Huang J; Chen Y; Jiang Y
Math Biosci Eng; 2022 Jun; 19(9):9295-9320. PubMed ID: 35942760
[TBL] [Abstract][Full Text] [Related]
53. Diagnostic and prognostic value of CEP55 in clear cell renal cell carcinoma as determined by bioinformatics analysis.
Zhou L; Liu S; Li X; Yin M; Li S; Long H
Mol Med Rep; 2019 May; 19(5):3485-3496. PubMed ID: 30896867
[TBL] [Abstract][Full Text] [Related]
54. Underexpression of hepatocyte nuclear factor-1β in chromophobe renal cell carcinoma.
Wang CC; Mao TL; Yang WC; Jeng YM
Histopathology; 2013 Mar; 62(4):589-94. PubMed ID: 23237209
[TBL] [Abstract][Full Text] [Related]
55. Correlating Transcriptional Networks to Papillary Renal Cell Carcinoma Survival: A Large-Scale Coexpression Analysis and Clinical Validation.
Feng X; Zhang M; Meng J; Wang Y; Liu Y; Liang C; Fan S
Oncol Res; 2020 May; 28(3):285-297. PubMed ID: 31948514
[TBL] [Abstract][Full Text] [Related]
56. A New Prognostic Risk Score: Based on the Analysis of Autophagy-Related Genes and Renal Cell Carcinoma.
He M; Li M; Guan Y; Wan Z; Tian J; Xu F; Zhou H; Gao M; Bi H; Chong T
Front Genet; 2021; 12():820154. PubMed ID: 35237298
[No Abstract] [Full Text] [Related]
57. Identification of core genes and outcomes in hepatocellular carcinoma by bioinformatics analysis.
Shen S; Kong J; Qiu Y; Yang X; Wang W; Yan L
J Cell Biochem; 2019 Jun; 120(6):10069-10081. PubMed ID: 30525236
[TBL] [Abstract][Full Text] [Related]
58. Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis.
Li Y; Li L
J Ovarian Res; 2019 Nov; 12(1):106. PubMed ID: 31703725
[TBL] [Abstract][Full Text] [Related]
59. Lox as the Potential Key Gene of Clear Cell Renal Carcinoma.
Chen Y; Yan Z; Su Y; Zhao S
J Coll Physicians Surg Pak; 2022 May; 32(5):632-638. PubMed ID: 35546701
[TBL] [Abstract][Full Text] [Related]
60. Acid, basic, and neutral peptidases present different profiles in chromophobe renal cell carcinoma and in oncocytoma.
Blanco L; Larrinaga G; Pérez I; López JI; Gil J; Agirregoitia E; Varona A
Am J Physiol Renal Physiol; 2008 Apr; 294(4):F850-8. PubMed ID: 18216146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]